mo:re
The company provides an integrated laboratory platform and hardware, including the MO:BOT, to automate the generation and analysis of 3D cell cultures like organoids and spheroids. Their system standardizes tissue culture protocols and analytical workflows to improve the predictive power of drug responses and disease models. The platform serves pharmaceutical researchers and laboratories by replacing manual handling with automated sample preparation and AI-assisted data reporting.
Visit websiteHamburg, Germany
Healthtech
Biotechnology
Life Sciences
Automation
Funding summary
- Total raised
- €2.3M
- Funding rounds
- 1
Investors in mo:re
Investors on record for mo:re. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like mo:re?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors